Get Started

CMPX

NASD Compass Therapeutics, Inc.
Oct 27, 2026 · 9:06 AM ET LAST TRADE Market Closed

$0.7574 ↑ +0.0102 (+1.37%) Trading Up from the previous close of $0.7472

YTD change
-85.90%
vs 20-day SMA
-16.20%
vs 200-day SMA
-76.95%

Price ranges

Previous day
$0.7409 $0.7925
open $0.7500 close $0.7472
-$0.0028 (-0.37%)
Today
$0.0000 $0.0000
$0.7574
Past week
$0.7409 $0.8679
from $0.8350 now $0.7574
-$0.0776 (-9.29%)
Past month
$0.7409 $1.1500
from $1.1100 now $0.7574
-$0.3526 (-31.77%)
This year
$0.7409 $6.8800
from $5.3700 now $0.7574
-$4.6126 (-85.90%)

Price & Performance

-1.04 (-58.26%) / 6M

$0.6046$1.29$1.98$2.67Apr 27Jul 28Oct 26

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 91.6% away from all-time highs of $9.0000
  • CMPX is down 86% since the beginning of the year
  • CMPX is down 82% over the past 12 months
  • CMPX is down 32% over the past 1 month
  • 28% of all CMPX investors are betting against CMPX

CMPX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -81.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.13
Earnings momentum -2.6% Quarterly EPS growth
Quarterly change -2.6%

Valuation

P/E ratio N/A
Enterprise value $-30670500.0
Beta 1.35

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$179.9M
Debt$9.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $136.4M

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $444.63 +1.22%
MRNA Moderna, Inc. $198.85 -0.62%
RVMD Revolution Medicines, Inc. $183.90 -1.65%
ROIV Roivant Sciences Ltd. $36.05 -1.21%
BNTX BioNTech SE Sponsored ADR $86.86 -1.42%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.